论文部分内容阅读
目的:对干扰素联合氨溴索雾化吸入对小儿病毒性肺炎的临床效果进行分析,进而探讨此种治疗手段在医疗中的应用价值。方法:对我院2016年2月-2017年2月前来我院进行治疗的188名患者进行分析研究,并将其随机分为两个不同的组别,即研究1组和研究2组,每组患者的人数均为94人。研究1组采用病毒唑雾化吸入的方式进行治疗,研究2组在常规治疗的基础上基础上加入干扰素以及氨溴索雾化治疗。并对两组患者的治疗有效率以及咳嗽、呼吸困难等症状的维持时间进行比较。结果:对两组患者的症状维持时间进行比较后发现,研究2组患者的咳嗽、呼吸困难等症状的维持时间均短于研究1组的患者,且研究2组患者的治疗有效率显著高于研究1组。同时,在经过不同治疗手段进行治疗后,两组患者的T淋巴细胞、辅助性T细胞以及T细胞生长因子水平均有所提高,阳性T细胞的水平均有所降低。结论:在治疗小儿病毒性肺炎的治疗中加入干扰素联合氨溴索雾化治疗的方式进行治疗,可以有效的改善治疗效果,减少疾病症状的持续时间,因此此种治疗方式值得在医疗中大力推广并使用。
OBJECTIVE: To analyze the clinical effect of interferon combined with ambroxol inhalation on pediatric viral pneumonia and to explore the value of this treatment in medical treatment. Methods: 188 patients who came to our hospital from February 2016 to February 2017 in our hospital were analyzed and randomly divided into two groups: study group 1 and study group 2, The number of patients in each group was 94. The first group was treated with inhaling ribavirin, and the other two groups were treated with interferon and ambroxol on the basis of routine treatment. The effectiveness of treatment and the maintenance of symptoms such as cough and dyspnea were compared between the two groups. Results: The comparison of symptom maintenance time between the two groups showed that the maintenance time of cough, dyspnea and other symptoms in both groups were shorter than that in study group 1, and the treatment efficiency in study group 2 was significantly higher than that in study group 1 Study 1 group. At the same time, T lymphocytes, helper T cells and T-cell growth factors were increased in both groups after treatment by different treatment methods, and the levels of positive T cells decreased. Conclusion: The treatment of children with viral pneumonia by adding interferon combined with ambroxol atomization treatment for treatment, which can effectively improve the treatment effect, reduce the duration of the disease symptoms, so this treatment is worth the medical treatment Promote and use.